Colorectal Cancer Trial, Recruiting NCT06914245 Sponsor: KU Leuven Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06914245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A person must give their voluntary written agreement to participate before any screening takes place (or a legally authorised representative may do so on their behalf).
  • People who are at least 18 years old at the time of signing the consent form.
  • People who are able to read, understand, and speak Dutch.
  • People who have been scheduled for a specific type of rectal cancer surgery (called Total Mesorectal Excision or Partial Mesorectal Excision) or who are on a 'Watch and Wait' programme for rectal cancer.

Who may not be able to join:

  • People who have had a different type of bowel surgery, such as a Hartmann procedure, abdominoperineal excision, transanal endoscopic microsurgery, or sigmoid resection.
  • People who had problems controlling their bowel movements (fecal incontinence) before their surgery.
  • People who have a neurological condition (a disorder affecting the brain, nerves, or spinal cord) that affects how their bowel works.
  • People who have previously had radiation therapy to the pelvic area or bowel surgery for reasons unrelated to cancer.
  • People who already have a permanent stoma (a surgically created opening on the abdomen for waste to leave the body).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Inge Geraerts, PhD, KU Leuven

Phone: +3216329120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
KU Leuven
Registry
ClinicalTrials.gov
Start date
28 April 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Bowel symptoms after rectal cancer treatment; The evaluation of Quality of Life (QoL) related to bowel symptoms after rectal cancer treatment; The evaluation of overall Quality of Life (QoL) after rectal cancer treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov